SEARCH:
Signup to create an account
test
Icahn Ups the Ante in Bid to Spin Off PayPal

Activist investor Carl Icahn upped the ante in its bid to push eBay Inc. (NASDAQ: EBAY) to spin off PayPal. In a DEF14A filing with the SEC, Mr. Icahn said that the complete disregard for accountability at eBay is the most blatant he's ever seen and strongly urged a number of changes designed to unlock value.

test
Two Ways to Invest in the Wireless Revolution

Most people thought Matt Rogers and Tony Fadell were crazy to leave Apple Inc. (NASDAQ: AAPL) in 2010 to try and start-up a small company focused on wireless home automation.


test
RXi Pharmaceuticals Moves Up to the NASDAQ Stock Exchange

RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, has made a lot of progress.

Recent 8K Filings
VECTOR GROUP LTD
NORTHERN STATES POWER CO
NORTHERN STATES POWER CO /WI/
PUBLIC SERVICE CO OF COLORADO
SOUTHWESTERN PUBLIC SERVICE CO
XCEL ENERGY INC
ENSCO PLC
SJW CORP
PS BUSINESS PARKS INC/CA

Recent Insider Filings
OPKO HEALTH, INC. (FROST PHILLIP MD ET AL)
AMPHENOL CORP /DE/ (CARROCCIA FRANK)
OVASCIENCE, INC. (STOCK HARALD F.)
BANCORP, INC. (CHRYSTAL JOHN C)
KENNAMETAL INC (BACCHUS JUDITH L)
DIME COMMUNITY BANCSHARES INC (HARRIS DANIEL J)
EZCORP INC (MACCARONE JODIE E. B.)
EZCORP INC (ROBERTS THOMAS CRAIG JR)
AMERICAN WOODMARK CORP (BRANDT WILLIAM F)



Executive Interview
Quantum Energy, Inc. (OTC: QEGY)
In this episode we speak with Mr. Russell Smith, EVP of Public Affairs for Quantum Energy, about the company's plans to build 21st Century Energy Centers in the Bakken oil fields.


Executive Interview
Theralase Technologies (OTC: TLTFF)
In this episode we will be talking to Mr. Roger Dumoulin-White, President & CEO of Theralase Technologies. Theralase designs, manufactures and markets patented, super-pulsed laser technology used in eliminating pain and destroying cancer.


Executive Interview
Galectin Therapeutics (NASDAQ: GALT)
In this SECFilings.com Executive Interview we speak with Mr. Jim Czirr, Executive Chairman of Galectin Therapeutics.



The page you have requested does not exist. We have recently renovated the website, so links from old email alerts may not work as intended. We thank you for your patience.